TCMD

Tactile Systems Technology, Inc.

$26.62

0.11%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

Source: Yahoo Finance
AI summary

Price & performance

1M+23.0%
3M-9.8%
YTD-0.8%
1Y+22.5%
52-week range—
Beta0.89
Full chart and returns against a benchmark

Q-Score

84/ 100

Quality against peers; 50 is the peer median.

Growth61
Risk65
Performance67
Valuation71
Profitability81
Leverage89
Sentiment83
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$329.5M+12.5%
Net income$19.1M+12.5%
Net margin5.8%+0.0 pts
Historical fundamentals

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer24%
Regions, segments, customers and suppliers

Valuation

TCMDIndustryP/E25.0429.61P/S1.673.49EV/EBITDA12.8718.38P/B2.623.39PEG0.810.81
Dividend yield0.00%
Every valuation metric

Earnings

Nov 2next report
EPS estimate$0.34
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate